Clinical Trials Directory

Trials / Completed

CompletedNCT05317884

Email-based Reminders Promoting Recommended Pediatric Preventative Visits

Evaluation of Email-based Reminders in Promoting Adherence to the Recommended Pediatric Preventative-visit Schedule Among Rural Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,186 (actual)
Sponsor
Geisinger Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess, prospectively, the effect of email reminders for well-child check (WCC) visits on adherence to these visits among those who have not yet scheduled the visit. The investigators hypothesize that sending reminders will increase scheduling WCC visits, attending WCC visits, and being up to date for the child's required immunizations beyond what occurs in the absence of these reminders.

Detailed description

Regular attendance at recommended WCC visits is associated with having up-to-date immunizations. Standard care involves scheduling a follow-up WCC visit at the end of the current visit. However, if the child's parents do not choose to schedule a follow-up visit at that time or miss a WCC visit, they may not be offered another easy opportunity to schedule one. That is, they would have to remember to schedule a visit and contact the clinic proactively. In this study, 30 days before a child is due for their WCC visit, parents who have not yet scheduled a WCC visit for up to 30 days (for 5-month-olds) or 60 days (for all other ages) after their child is due for a visit will be randomly assigned to two groups with a random number generator. One group will receive an email reminder, while the other group will not receive any reminder. The randomization of participants to different conditions will be in place until 800 participants have been identified and randomly assigned to one of the arms (estimated sample to detect at least a 10% absolute difference) or 180 days, whichever comes first. To account for delays in updating clinical databases, the final outcome data will be checked 90 days after the last eligible visit (for a maximum study period of 270 days).

Conditions

Interventions

TypeNameDescription
BEHAVIORALReminderEmail

Timeline

Start date
2022-05-16
Primary completion
2022-09-13
Completion
2022-09-13
First posted
2022-04-08
Last updated
2022-11-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05317884. Inclusion in this directory is not an endorsement.